Analyst consensus rating
AC Immune Analyst Rating: Strong Buy
ACIU is rated Strong Buy by 4 analysts with a $8.52 target. As of 2026-08-30.
Direct answer
AC Immune's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.52.
Forecast evidence checked August 30, 2026.
Get free AC Immune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.65
- Average price target
- $8.52
- High price target
- $11.84
- Low price target
- $5.34
- Low target gap
- +101.7%
- Target upside
- +221.6%
- High target gap
- +347%
- Target range width
- 245.3%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 30, 2026
- Valid through
- September 6, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for AC Immune?
AC Immune has a verified Strong Buy consensus. The same dataset has an average price target of $8.52.
How far are AC Immune's low and high targets from the recorded price?
The low target implies +101.7%, while the high target implies +347%.
How many analysts are included in AC Immune's consensus?
The verified consensus includes 4 analysts.
How is AC Immune's target upside or downside calculated?
The average target of $8.52 is divided by the recorded price of $2.65, then one is subtracted to produce +221.6%. This does not guarantee a future return.
When was AC Immune's analyst forecast verified?
The data was verified on 2026-08-30. The dataset is valid through 2026-09-06.